Cart
sales@molnova.com
TLC2976-0103
CAS No. 692869-38-8
TLC2976-0103( —— )
Catalog No. M37683 CAS No. 692869-38-8
ROCK1-IN-1 is an inhibitor of ROCK1 with a K i value of 540 nM. ROCK1-IN-1 can be used in the research of hypertension, glaucoma and erectile dysfunction .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 69 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 164 | Get Quote |
|
| 50MG | 250 | Get Quote |
|
| 100MG | 354 | Get Quote |
|
| 200MG | 496 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTLC2976-0103
-
NoteResearch use only, not for human use.
-
Brief DescriptionROCK1-IN-1 is an inhibitor of ROCK1 with a K i value of 540 nM. ROCK1-IN-1 can be used in the research of hypertension, glaucoma and erectile dysfunction .
-
DescriptionROCK1-IN-1 is a ROCK1 inhibitor with a Ki value of 540 nM. ROCK1-IN-1 can be used for the research of hypertension, glaucoma and erectile dysfunction.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number692869-38-8
-
Formula Weight325.38
-
Molecular FormulaC17H15N3O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (384.17 mM; Ultrasonic (<60°C)
-
SMILESCOc1ccc(CC(=O)Nc2nc(cs2)-c2ccncc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Green J, et al. Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors. J Med Chem. 2015 Jun 25;58(12):5028-37.?
molnova catalog
related products
-
Terbutryn
Terbutryn is a selective herbicide and a triazine compound. It acts as an inhibitor of photosynthesis.
-
NS-2710
NS-2710 is a non-selective GABA(A) receptor partial agonist for the study of anxiety disorders.
-
Arg-Gly-Asp-Cys
Arg-Gly-Asp-Cys is the binding motif of fibronectin and cell adhesion molecules, which can inhibit platelet aggregation and fibrinogen binding.
